Fundacao Oswaldo Cruz

RJ Doing business as Fiocruz

UEI
T74JLSK1LJM8
CAGE
00U2K
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Interstate Entity
  • Foundation
  • Foreign Government
  • Planning Commission
  • Council of Governments
Entity structure
Country - Foreign Government
SAM.gov registration date
Physical address
Av. Brasil, 4365 - 303 - Manguinhos, Rio de Janeiro - RJ, 21040-360, Brazil
Website
fiocruz.br
Founded
2001
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Angola BSS data analysis 6M02A HHSD2002011M37633P CDC Office of Acquisition Services $49,551

Grant awards

Award Agency Obligated Awarded
An extracellular vesicle component as a candidate to control cryptococcosis. Summary fungal diseases are a major threat… R01AI183314 National Institute of Allergy and Infectious Diseases (NIH) $612,092
The impact of social drivers, conditional cash transfers and their mechanisms on mental health of the young: an… R01MH128911 National Institute of Mental Health (NIH) $4,528,230
Study on the persistence of zika virus (ZIKV) in body fluids of patients with ZIKV infection in brazil R21AI139777 National Institute of Allergy and Infectious Diseases (NIH) $272,484
The role of tregs and lipid mediators in the progression of mycobacterium leprae infection to active disease R01AI129835 National Institute of Allergy and Infectious Diseases (NIH) $1,008,480
GH13-1343: strengthen brazil's national response to HIV and other diseas U2GGH001152 Centers for Disease Control and Prevention $3,390,999

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
The General Hospital Corporation Hepatitis B virus (HBV) infection remains a major threat to global health, where approximately 300 million persons worldwide are infected. Due to its… R01AI184931 $320,448
University Of Washington University of Washington Arboviral Research Network (UWARN). U01AI151698 $135,000
The General Hospital Corporation Hepatitis B virus (HBV) infection remains a major threat to global health, where approximately 300 million persons worldwide are infected. Due to its… R01AI184931 $160,224
Brown University IPEC Fiocruz will serve as the primary recruitment and study site for this project in Rio de Janeiro, Brazil. Dr. Beatriz Grinsztejn will serve as Site… R34MH126894 $77,333
University Of Washington University of Washington Arboviral Research Network (UWARN). U01AI151698 $21,844

Similar vendors

Vendor Location Primary NAICS
Fiotec - Fundacao Para O Desenvolvimento Cientifico E Tecnologico Em Saude UEI H8YMGVK36S97 RJ 541611 Administrative Management and General Management Consulting Services
Fundacao De Desenvolvimento DA Pesquisa UEI KLG7K5NUCH39 MG 541690 Other Scientific and Technical Consulting Services
FFM UEI LAX5CEV3LL74 SP 541720 Research and Development in the Social Sciences and Humanities
Reitoria DA Universidade De SAO Paulo UEI CDQJMC1HN7R8 SP —
College Of Health Sciences, University Of Ghana UEI JMP4KX9ZY7Q4 Accra, Greater Accra Region 611310 Colleges, Universities, and Professional Schools

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Fundacao Oswaldo Cruz, doing business as Fiocruz, is a prominent Brazilian public health research institution that has been registered to receive U.S. federal government awards since November 2007. As a foreign government entity classified as an interstate entity, foundation, planning commission, and council of governments, Fiocruz primarily engages in scientific research and public health initiatives, focusing on areas such as infectious diseases, mental health, and social determinants of health. The institution provides a wide range of services to the federal government through federal grant awards, including conducting large-scale epidemiological studies, developing innovative treatments for infectious diseases, and addressing complex public health challenges in low- and middle-income countries. Fiocruz is renowned for its expertise in biomedical research and public health interventions, making it a valuable partner for U.S. federal agencies seeking to advance global health initiatives.

Through its prime and sub federal grant awards, Fiocruz has been involved in diverse research projects and collaborations. The institution has received prime federal grant awards from agencies such as the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH). These grants support projects like investigating extracellular vesicle components as potential treatments for cryptococcosis and studying the impact of social drivers and conditional cash transfers on youth mental health in Brazil. Additionally, Fiocruz has participated in several sub-grant awards, collaborating with institutions like the University of Washington on the University of Washington Arboviral Research Network (UWARN) project, and with Brown University on HIV prevention studies. The institution's involvement in these grants demonstrates its capacity to conduct research on a wide range of topics, including infectious diseases, mental health, and public health interventions. Fiocruz's work often involves large-scale data analysis, clinical trials, and the development of new therapeutic approaches, contributing significantly to global efforts in improving public health outcomes.

Quick answers

Is Fundacao Oswaldo Cruz registered in SAM.gov?

Yes. Fundacao Oswaldo Cruz's SAM.gov registration is active through March 9, 2027.

What is Fundacao Oswaldo Cruz's CAGE code?

Fundacao Oswaldo Cruz's CAGE code is 00U2K, and its Unique Entity ID (UEI) is T74JLSK1LJM8.

What is Fundacao Oswaldo Cruz's most recent federal award?

Fundacao Oswaldo Cruz's most recent federal grant award is An extracellular vesicle component as a candidate to control cryptococcosis. Summary fungal diseases are a major threat… (R01AI183314), from National Institute of Allergy and Infectious Diseases (NIH), on March 21, 2024.

On GovTribe

See Fundacao Oswaldo Cruz's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe